Invitrogen launches new business unit

The company’s new business unit will be responsible for integrating relevant technologies including Dynal magnetic beads for cell isolation, Gibco cell expansion media and Molecular Probes cell characterization tools to meet the needs of companies and researchers involved in developing cell therapies.

Joydeep Goswami, Invitrogen’s vice president, stem cells and regenerative medicine, said: “We bring project management capabilities to the table, pulling together tools, reagents, and services from across the company to meet the specific needs of cell therapy companies. By offering integrated solutions, we can help accelerate the field toward groundbreaking therapies.”